Advertisement

Table of Contents

June 27, 2019; 133 (26)

BLOOD COMMENTARIES

CLINICAL TRIALS AND OBSERVATIONS

GENE THERAPY

LYMPHOID NEOPLASIA

  • Hydroa vacciniforme–like lymphoproliferative disorder: an EBV disease with a low risk of systemic illness in whites
    Hydroa vacciniforme–like lymphoproliferative disorder: an EBV disease with a low risk of systemic illness in whites
    Jeffrey I. Cohen, Irini Manoli, Kennichi Dowdell, Tammy A. Krogmann, Deborah Tamura, Pierce Radecki, Wei Bu, Siu-Ping Turk, Kelly Liepshutz, Ronald L. Hornung, Hiva Fassihi, Robert P. Sarkany, Lori L. Bonnycastle, Peter S. Chines, Amy J. Swift, Timothy G. Myers, Melissa A. Levoska, John J. DiGiovanna, Francis S. Collins, Kenneth H. Kraemer, Stefania Pittaluga and Elaine S. Jaffe
  • Phase 1b study of venetoclax-obinutuzumab in previously untreated and relapsed/refractory chronic lymphocytic leukemia
    Phase 1b study of venetoclax-obinutuzumab in previously untreated and relapsed/refractory chronic lymphocytic leukemia
    Ian W. Flinn, John G. Gribben, Martin J. S. Dyer, William Wierda, Michael B. Maris, Richard R. Furman, Peter Hillmen, Kerry A. Rogers, Swaminathan Padmanabhan Iyer, Anne Quillet-Mary, Loic Ysebaert, Harriet S. Walter, Maria Verdugo, Christian Klein, Huang Huang, Yanwen Jiang, Gerard Lozanski, Daniela Soriano Pignataro, Kathryn Humphrey, Mehrdad Mobasher and Thomas J. Kipps
  • Recurrent <em>MSC</em><sup>E116K</sup> mutations in ALK-negative anaplastic large cell lymphoma
    Recurrent MSCE116K mutations in ALK-negative anaplastic large cell lymphoma
    Rebecca A. Luchtel, Michael T. Zimmermann, Guangzhen Hu, Surendra Dasari, Manli Jiang, Naoki Oishi, Hailey K. Jacobs, Yu Zeng, Tanya Hundal, Karen L. Rech, Rhett P. Ketterling, Jeong-Heon Lee, Bruce W. Eckloff, Huihuang Yan, Krutika S. Gaonkar, Shulan Tian, Zhenqing Ye, Marshall E. Kadin, Jagmohan Sidhu, Liuyan Jiang, Jesse Voss, Brian K. Link, Sergei I. Syrbu, Fabio Facchetti, N. Nora Bennani, Susan L. Slager, Tamas Ordog, Jean-Pierre Kocher, James R. Cerhan, Stephen M. Ansell and Andrew L. Feldman

TRANSPLANTATION

LETTERS TO BLOOD

BLOOD WORK